{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:02:35Z","timestamp":1793646155574,"version":"4.5.1"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.psychres.2022.114840","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T12:33:32Z","timestamp":1662726812000},"page":"114840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update"],"prefix":"10.1016","volume":"317","author":[{"given":"Laura A.","family":"Bajor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmi","family":"Balsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Osser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/00207140802039672","article-title":"Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial","volume":"56","author":"Abramowitz","year":"2008","journal-title":"Int. J. Clin. Exp. Hypn."},{"key":"10.1016\/j.psychres.2022.114840_bib0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpsychires.2014.07.014","article-title":"The cumulative effect of different childhood trauma types on self-reported symptoms of adult male depression and PTSD, substance abuse and health-related quality of life in a large active-duty military cohort","volume":"58","author":"Agorastos","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2022.114840_bib0003","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.brainresbull.2018.06.001","article-title":"Unilateral right and bilateral dorsolateral prefrontal cortex transcranial magnetic stimulation in treatment post-traumatic stress disorder: a randomized controlled study","volume":"140","author":"Ahmadizadeh","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.psychres.2022.114840_bib0004","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainresbull.2019.09.011","article-title":"Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): a randomized, double-blinded, controlled trial","volume":"153","author":"Ahmadizadeh","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000362243","article-title":"Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder","volume":"69","author":"Ahmadpanah","year":"2014","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.18ac12473","article-title":"Are there effective psychopharmacologic treatments for PTSD?","volume":"80","author":"Akiki","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0007","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.4088\/JCP.17m11634","article-title":"Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression","volume":"79","author":"Albott","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0008","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.4088\/JCP.14m09057","article-title":"Early discontinuation and suboptimal dosing of prazosin: a potential missed opportunity for veterans with posttraumatic stress disorder","volume":"76","author":"Alexander","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"10037","key":"10.1016\/j.psychres.2022.114840_bib0009","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet N. Am. Ed."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0010","first-page":"772","article-title":"ACOG guidelines on psychiatric medication use during pregnancy and lactation","volume":"78","author":"Armstrong","year":"2008","journal-title":"Am. Fam. Phys."},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0011","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hup.426","article-title":"Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study","volume":"17","author":"Bahk","year":"2002","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10673229.2011.614483","article-title":"The psychopharmacology algorithm project at the Harvard south shore program: an update on posttraumatic stress disorder","volume":"19","author":"Bajor","year":"2011","journal-title":"Harv. Rev. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/14728210902972494","article-title":"Post-traumatic stress disorder: emerging concepts of pharmacotherapy","volume":"14","author":"Baker","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"issue":"8","key":"10.1016\/j.psychres.2022.114840_bib0014","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/acer.12496","article-title":"Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial","volume":"38","author":"Batki","year":"2014","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.psychres.2022.114840_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112583","article-title":"The psychopharmacology algorithm project at the Harvard south shore program: an algorithm for adults with obsessive-compulsive disorder","volume":"281","author":"Beaulieu","year":"2019","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0016","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/JCP.0b013e318032eaed","article-title":"A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder","volume":"27","author":"Becker","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1037\/adb0000355","article-title":"Alcohol, cannabis, and other drug use: engagement and outcome in PTSD treatment","volume":"32","author":"Bedard-Gilligan","year":"2018","journal-title":"Psychol. Addict. Behav."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0018","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/NMD.0b013e3181961d8e","article-title":"Impact of sleep disturbances on PTSD symptoms and perceived health","volume":"197","author":"Belleville","year":"2009","journal-title":"J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0019","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11920-015-0564-2","article-title":"Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?","volume":"17","author":"Bernardy","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0020","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/npp.2011.310","article-title":"Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia","volume":"37","author":"Bettica","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.bp.106.021402","article-title":"Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis","volume":"190","author":"Bisson","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246990","article-title":"The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: a randomized cross-over clinical trial","volume":"16","author":"Bonn-Miller","year":"2021","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.psychres.2022.114840_bib0023","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"issue":"Suppl 9","key":"10.1016\/j.psychres.2022.114840_bib0024","first-page":"12","article-title":"Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD","volume":"58","author":"Brady","year":"1997","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0025","first-page":"236","article-title":"Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment","volume":"51","author":"Braun","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0026","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jpsychires.2021.03.008","article-title":"Low-dose clonidine in veterans with Posttraumatic stress disorder","volume":"137","author":"Burek","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0027","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/JCP.0b013e3181dac52f","article-title":"Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety","volume":"30","author":"Byers","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0029","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-199810000-00005","article-title":"Bupropion treatment in veterans with posttraumatic stress disorder: an open study","volume":"18","author":"Canive","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114840_bib0028","series-title":"Proceedings of the Thematic Meeting for the Collegium Internationale Neuro-psychopharmacologicum (CINP)","article-title":"Quetiapine monotherapy in chronic posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial (P050)","author":"Canive","year":"2009"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/wps.20579","article-title":"Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis","volume":"17","author":"Carbon","year":"2018","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0031","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hup.2238","article-title":"Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study","volume":"27","author":"Carey","year":"2012","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.psychres.2022.114840_bib0032","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jad.2018.04.009","article-title":"5Hz repetitive transcranial magnetic stimulation for posttraumatic stress disorder comorbid with major depressive disorder","volume":"235","author":"Carpenter","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0033","first-page":"16","article-title":"Real-world data on SSRI antidepressant side effects","volume":"6","author":"Cascade","year":"2009","journal-title":"Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0034","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.4088\/JCP.16r10897","article-title":"Patients with co-occurring bipolar disorder and posttraumatic stress disorder: a rapid review of the literature","volume":"78","author":"Cerimele","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.55.10.913","article-title":"Posttraumatic stress disorder and drug disorders: testing causal pathways","volume":"55","author":"Chilcoat","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0036","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hup.615","article-title":"Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial","volume":"19","author":"Chung","year":"2004","journal-title":"Hum. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0037","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5664\/jcsm.2260","article-title":"The impact of posttraumatic stress disorder on CPAP adherence in patients with obstructive sleep apnea","volume":"8","author":"Collen","year":"2012","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.psychres.2022.114840_bib0038","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pnpbp.2018.08.001","article-title":"Posttraumatic stress disorder with secondary psychotic features (PTSD-SP): diagnostic and treatment challenges","volume":"88","author":"Compean","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0039","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/15299732.2016.1267682","article-title":"Auditory hallucinations and PTSD in ex-POWS","volume":"18","author":"Crompton","year":"2017","journal-title":"J. Trauma Dissociation"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4088\/JCP.v60n0106","article-title":"Psychotic symptoms in combat-related posttraumatic stress disorder","volume":"60","author":"David","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0044","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1990.01810150059010","article-title":"Treatment of posttraumatic stress disorder with amitriptyline and placebo","volume":"47","author":"Davidson","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0047","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder","volume":"58","author":"Davidson","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib197","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-3223(02)01411-7","article-title":"Mirtazapine vs. placebo in possttraumatic stress disorder: a pilot trial","volume":"53","author":"Davidson","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2022.114840_bib0043","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3928\/00485713-20051101-04","article-title":"A new treatment algorithm for posttraumatic stress disorder","volume":"35","author":"Davidson","year":"2005","journal-title":"Psychiatr. Ann."},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0042","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.63.10.1158","article-title":"Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial","volume":"63","author":"Davidson","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.jcp.0000222514.71390.c1","article-title":"Venlafaxine extended release in posttraumatic stress disorder: a sertraline-and placebo-controlled study","volume":"26","author":"Davidson","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/JCP.0b013e31802e5115","article-title":"The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder","volume":"27","author":"Davidson","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0041","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/0269881114565143","article-title":"Vintage treatments for PTSD: a reconsideration of tricyclic drugs","volume":"29","author":"Davidson","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0048","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0b013e318160f83b","article-title":"Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population","volume":"28","author":"Davis","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0049","first-page":"8","article-title":"A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans","volume":"41","author":"Davis","year":"2008","journal-title":"Psychopharmacol. Bull."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib192","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13267","article-title":"A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in veterans","volume":"81","author":"Davis","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2022.114840_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/jcm5120117","article-title":"Treatment of post-traumatic stress disorder nightmares at a veterans affairs medical center","volume":"5","author":"Detweiler","year":"2016","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0051","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10401230209147450","article-title":"The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists","volume":"14","author":"Dording","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0052","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5498\/wjp.v10.i3.21","article-title":"Double-blind randomized controlled study of the efficacy, safety and tolerability of eszopiclone vs placebo for the treatment of patients with post-traumatic stress disorder and insomnia","volume":"10","author":"Dowd","year":"2020","journal-title":"World J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0053","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/JCP.0000000000001363","article-title":"Efficacy of vortioxetine monotherapy for posttraumatic stress disorder: a randomized, placebo-controlled trial","volume":"41","author":"Dunlop","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114840_bib0054","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jad.2015.04.054","article-title":"Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial","volume":"184","author":"El-Mallakh","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0055","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/acm.2018.0437","article-title":"Cannabidiol in the treatment of post-traumatic stress disorder: a case series","volume":"25","author":"Elms","year":"2019","journal-title":"J. Altern. Complement. Med."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0057","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0058","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/bs.apha.2020.05.004","article-title":"The emergence of ketamine as a novel treatment for posttraumatic stress disorder","volume":"89","author":"Feder","year":"2020","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0056","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A Randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0059","series-title":"Effective Treatments For PTSD: Practice Guidelines from the International Society For Traumatic Stress Studies","author":"Foa","year":"2010"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4088\/JCP.v68n0508","article-title":"Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a department of veterans affairs setting","volume":"68","author":"Friedman","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0062","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychores.2011.11.010","article-title":"Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US military veterans","volume":"72","author":"Germain","year":"2012","journal-title":"J. Psychosom. Res."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0061","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1176\/appi.ajp.2012.12040432","article-title":"Sleep disturbances as the hallmark of PTSD: where are we now?","volume":"170","author":"Germain","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0063","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/HRP.0000000000000197","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: an update on unipolar nonpsychotic depression","volume":"27","author":"Giakoumatos","year":"2019","journal-title":"Harvard. Rev. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0064","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s11136-013-0585-4","article-title":"The association of PTSD with physical and mental health functioning and disability (VA Cooperative Study #569: the course and consequences of posttraumatic stress disorder in Vietnam-era veteran twins)","volume":"23","author":"Goldberg","year":"2014","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0066","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the New Mexico medical cannabis program","volume":"46","author":"Greer","year":"2014","journal-title":"J. Psychoact. Drugs"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0067","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-3223(98)00016-X","article-title":"Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study","volume":"44","author":"Grisaru","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0068","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/jwh.2019.8082","article-title":"Sex differences in associations between depression and posttraumatic stress disorder symptoms and tobacco use among veterans of recent conflicts","volume":"29","author":"Gross","year":"2020","journal-title":"J. Women's Health"},{"issue":"8","key":"10.1016\/j.psychres.2022.114840_bib0069","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/jcm5080070","article-title":"PTSD symptom severities, interpersonal traumas, and benzodiazepines are associated with substance-related problems in trauma patients","volume":"5","author":"Guina","year":"2016","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13181-013-0294-y","article-title":"In the Zzz zone: the effects of Z-drugs on human performance and driving","volume":"9","author":"Gunja","year":"2013","journal-title":"J. Med. Toxicol."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0071","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10401230109148960","article-title":"Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy","volume":"13","author":"Hamner","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0072","doi-asserted-by":"crossref","DOI":"10.1177\/104012370902100205","article-title":"A preliminary controlled trial of divalproex in posttraumatic stress disorder","author":"Hamner","year":"2009","journal-title":"Ann. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0073","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/JCP.0000000000001000","article-title":"Ziprasidone augmentation of SSRI antidepressants in posttraumatic stress disorder: a randomized, placebo-controlled pilot study of augmentation therapy","volume":"39","author":"Hamner","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0074","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/AAP.0000000000000402","article-title":"Stellate ganglion block for the treatment of posttraumatic stress disorder: a randomized, double-blind, controlled trial","volume":"41","author":"Hanling","year":"2016","journal-title":"Reg. Anesth. Pain Med."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00213-017-4786-3","article-title":"Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study","volume":"235","author":"Hartberg","year":"2018","journal-title":"Psychopharm"},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0076","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","article-title":"A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder","volume":"45","author":"Hertzberg","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0077","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.2020.22106","article-title":"Balancing the risks and benefits of benzodiazepines","volume":"325","author":"Hirschtritt","year":"2021","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.psychres.2022.114840_bib0078","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1001\/jama.2021.4513","article-title":"Risks and benefits of benzodiazepines","volume":"325","author":"Horowitz","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0079","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.bp.114.148551","article-title":"Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis","volume":"206","author":"Hoskins","year":"2015","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0080","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2021.04.019","article-title":"Deep transcranial magnetic stimulation combined with brief exposure for posttraumatic stress disorder: a prospective multisite randomized trial","volume":"90","author":"Isserles","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0081","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00213-020-05548-2","article-title":"Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","volume":"237","author":"Jerome","year":"2020","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0082","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.22119","article-title":"Sudden gains in prolonged exposure and sertraline for chronic PTSD","volume":"30","author":"Jun","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2022.114840_bib0083","unstructured":"Kansagara D., O'Neil M., Nugent S., et\u00a0al., 2017. Benefits and harms of cannabis in chronic pain or post-traumatic stress disorder: a systematic review. Washington, DC: Department of Veterans Affairs. PMID: 29369568."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0084","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2003.06.006","article-title":"The effects of trazodone on sleep in patients treated with stimulant antidepressants","volume":"5","author":"Kaynak","year":"2004","journal-title":"Sleep Med."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1001\/jamapsychiatry.2018.3410","article-title":"Use of prolonged exposure and sertraline in the treatment ofposttraumatic stress disorder for veterans","volume":"76","author":"Kaysen","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2022.114840_bib0086","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/da.22828","article-title":"Posttraumatic stress disorder and cigarette smoking: a systematic review","volume":"35","author":"Kearns","year":"2018","journal-title":"Depress. Anxiety"},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0087","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archpsyc.62.7.709","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. (vol 62, pg 617, 2005)","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatr."},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0088","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005053-198909000-00005","article-title":"Clonidine in Cambodian patients with posttraumatic stress disorder","volume":"177","author":"Kinzie","year":"1989","journal-title":"J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0089","first-page":"660","article-title":"Polysomnographically measured sleep abnormalities in PTSD: a meta-analytic review","volume":"44","author":"Kobayashi","year":"2007","journal-title":"Psychophysiology"},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-199106000-00011","article-title":"Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine","volume":"179","author":"Kosten","year":"1991","journal-title":"J. Nerv. Ment. Dis."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0091","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S1461145706006596","article-title":"Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features","volume":"10","author":"Kozaric-Kovacic","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2022.114840_bib0092","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.psychres.2019.01.004","article-title":"One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial","volume":"273","author":"Kozel","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2022.114840_bib0093","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smrv.2014.11.001","article-title":"Posttraumatic stress disorder and sleep-disordered breathing: a review of comorbidity research","volume":"24","author":"Krakow","year":"2015","journal-title":"Sleep Med. Rev."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0095","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2011.1080","article-title":"Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial","volume":"306","author":"Krystal","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0094","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4088\/JCP.14m09585","article-title":"Sleep disturbance in chronic military-related PTSD: clinical impact and response to adjunctive risperidone in the veterans affairs cooperative study #504","volume":"77","author":"Krystal","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2022.114840_bib0096","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","article-title":"Benzodiazepines revisited\u2014will we ever learn?","volume":"106","author":"Lader","year":"2011","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0097","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/da.22511","article-title":"Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: systemic review and meta-analyses to determine first-line treatments","volume":"33","author":"Lee","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psychres.2022.114840_bib0098","series-title":"Proceedings of the NIH State-of-the-Science Conference","first-page":"1","article-title":"NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults","author":"Leshner","year":"2005"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0099","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/13651501.2017.1291838","article-title":"Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study","volume":"21","author":"Li","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0100","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/jcp.0b013e31815a43ee","article-title":"A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder","volume":"27","author":"Lindley","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"212305","key":"10.1016\/j.psychres.2022.114840_bib0101","article-title":"Ketamine as treatment for post-traumatic stress disorder: a review","volume":"8","author":"Liriano","year":"2019","journal-title":"Drugs Context"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0102","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11839","article-title":"Association of cannabis with long-term clinical symptoms in anxiety and mood disorders: a systematic review of prospective studies","volume":"79","author":"Mammen","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2022.114840_bib193","doi-asserted-by":"crossref","first-page":"e2104","DOI":"10.7205\/MILMED-D-17-00072","article-title":"Recurrent priapism in a military veteran receiving treatment for PTSD","volume":"182","author":"Mann","year":"2017","journal-title":"Mil. Med."},{"issue":"12","key":"10.1016\/j.psychres.2022.114840_bib0103","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study","volume":"158","author":"Marshall","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/da.20176","article-title":"A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults","volume":"24","author":"Marshall","year":"2007","journal-title":"Depress. Anxiety"},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0105","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/JCP.0000000000000968","article-title":"A pilot,randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares","volume":"38","author":"McCall","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0106","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/15402002.2017.1326920","article-title":"Caffeine use in military personnel with PTSD: prevalence and impact on sleep","volume":"17","author":"McLean","year":"2019","journal-title":"Behav. Sleep Med."},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0107","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.biopsych.2003.12.018","article-title":"Heart rate variability during sleep and the early development of posttraumatic stress disorder","volume":"55","author":"Mellman","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0108","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2022.114840_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S1461145708009164","article-title":"Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers","volume":"12","author":"Murphy","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0111","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.5664\/jcsm.4120","article-title":"Trauma associated sleep disorder: a proposed parasomnia encompassing disruptive nocturnal behaviors, nightmares, and REM without atonia in trauma survivors","volume":"10","author":"Mysliwiec","year":"2014","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.psychres.2022.114840_bib0113","series-title":"National Clinical Practice Guideline Number 26. Gaskell and the British Psychological Society","article-title":"Post-traumatic stress disorder: the management of PTSD in adults and children and secondary care","year":"2005"},{"key":"10.1016\/j.psychres.2022.114840_bib0112","series-title":"Post-traumatic Stress Disorder","year":"2018"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0114","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/YIC.0000000000000061","article-title":"A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military veterans resistant to antidepressant treatment","volume":"30","author":"Naylor","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114840_bib0115","series-title":"Delayed Ejaculation and orgasm, Men's Sexual Health and Fertility","first-page":"145","author":"Nelson","year":"2014"},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1176\/ajp.155.7.929","article-title":"Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans","volume":"155","author":"Neylan","year":"1998","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2022.114840_bib0116","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1176\/ajp.2006.163.12.2186","article-title":"No improvement of posttraumatic stress disorder symptoms with guanfacine treatment","volume":"163","author":"Neylan","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0118","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/YCO.0000000000000158","article-title":"Distinguishing schizophrenia from posttraumatic stress disorder with psychosis","volume":"28","author":"O'Conghaile","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamapsychiatry.2019.3474","article-title":"Effect of stellate ganglion block treatment on posttraumatic stress disorder symptoms: a randomized clinical trial","volume":"77","author":"Olmsted","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0121","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0120","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/medicina55090525","article-title":"Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review","volume":"55","author":"Orsolini","year":"2019","journal-title":"Medicina"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0122","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3928\/0048-5713-19990501-10","article-title":"Algorithms for the pharmacotherapy of anxiety disorders in patients with chemical abuse and dependence","volume":"29","author":"Osser","year":"1999","journal-title":"Psychiatr. Ann."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0123","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.2018.19290","article-title":"Management of posttraumatic stress disorder","volume":"321","author":"Ostacher","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0124","first-page":"29","article-title":"Is transcranial magnetic stimulation effective in treatment-resistant combat related posttraumatic stress disorder?","volume":"19","author":"Oznur","year":"2014","journal-title":"Neurosci. J."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32825ea324","article-title":"The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials","volume":"23","author":"Pae","year":"2008","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0127","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/npp.2011.283","article-title":"Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence","volume":"37","author":"Petrakis","year":"2012","journal-title":"Neuropsychopharm"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/acer.12926","article-title":"Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: a clinical trial","volume":"40","author":"Petrakis","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/00048674211041917","article-title":"Australian guidelines for the prevention and treatment of posttraumatic stress disorder: updates in the third edition","volume":"56","author":"Phelps","year":"2022","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2022.114840_bib0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1176\/appi.ajp.2019.18101160","article-title":"Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder","volume":"176","author":"Philip","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib195","first-page":"29","article-title":"Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety?","volume":"6","author":"Pies","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0131","first-page":"451","article-title":"Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder","volume":"175","author":"Pivac","year":"2004","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0132","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.09m05607gry","article-title":"Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial","volume":"72","author":"Pollack","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conctc.2015.12.003","article-title":"Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder","volume":"2","author":"Ramaswamy","year":"2016","journal-title":"Contemp. Clin. Trials Commun."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0133","first-page":"26993","article-title":"A double-blind, placebo-controlled randomized trial of vilazodone in the treatment of posttraumatic stress disorder and comorbid depression","volume":"19","author":"Ramaswamy","year":"2017","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study","volume":"160","author":"Raskind","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2022.114840_bib0137","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder","volume":"61","author":"Raskind","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0139","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","article-title":"A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan","volume":"170","author":"Raskind","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biopsych.2016.03.2108","article-title":"Higher pretreatment blood pressure is associated with greater posttraumatic stress disorder symptom reduction in soldiers treated with prazosin","volume":"80","author":"Raskind","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0136","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1507598","article-title":"Trial of prazosin for post-traumatic stress disorder in military veterans","volume":"378","author":"Raskind","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapsychiatry.2018.3412","article-title":"Efficacy of prolonged exposure therapy, sertraline hydrochloride, and their combination among combat veterans with posttraumatic stress disorder: a randomized clinical trial","volume":"76","author":"Rauch","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib194","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2022.114840_bib0141","article-title":"Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports","volume":"351","author":"Reefhuis","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0142","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.sxmr.2017.05.002","article-title":"Sexual consequences of post-SSRI syndrome","volume":"5","author":"Reisman","year":"2017","journal-title":"Sex Med. Rev."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0143","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1176\/ajp.146.4.513","article-title":"A controlled trial of desipramine in 18 men with posttraumatic stress disorder","volume":"146","author":"Reist","year":"1989","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0144","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004714-200210000-00012","article-title":"Tolerance to daytime sedative effects of H1 antihistamines","volume":"22","author":"Richardson","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0145","first-page":"69","article-title":"An open-label assessment of aripiprazole in the treatment of PTSD","volume":"42","author":"Robert","year":"2009","journal-title":"Psychopharmacol. Bull."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0146","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0033291710000401","article-title":"Race\/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States","volume":"41","author":"Roberts","year":"2011","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0147","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.4088\/JCP.14m09681","article-title":"Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial","volume":"77","author":"Rodgman","year":"2016","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2022.114840_bib0148","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4088\/JCP.13m08592","article-title":"Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder?","volume":"74","author":"Rosen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0149","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4088\/JCP.v69n1002","article-title":"A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo","volume":"69","author":"Rothbaum","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0150","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.v69n0402","article-title":"Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder","volume":"69","author":"Rothbaum","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0151","first-page":"26","article-title":"Demographic variation in the use of prazosin for treatment of sleep disturbance in combat veterans with PTSD","volume":"50","author":"Rubin","year":"2020","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.psychres.2022.114840_bib0152","series-title":"Trazodone, Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment","first-page":"237","author":"Sadock","year":"2001"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0153","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1mg, 3mg, and 6mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study","volume":"69","author":"Scharf","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2022.114840_bib0154","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/da.22384","article-title":"Combined mirtazapine and ssri treatment of PTSD: a placebo-controlled trial","volume":"32","author":"Schneier","year":"2015","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/da.22477","article-title":"Symptom benchmarks of improved quality of life in PTSD","volume":"33","author":"Schnurr","year":"2016","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190022","article-title":"Patterns of zolpidem use among Iraq and Afghanistan veterans: a retrospective cohort analysis","volume":"13","author":"Shayegani","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0157","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-1781(88)90057-1","article-title":"A controlled trial of phenelzine in posttraumatic stress disorder","volume":"24","author":"Shestatzky","year":"1988","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib0158","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0159","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1176\/appi.ajp.2020.20050609","article-title":"Moderation of prazosin's efficacy by alcohol withdrawal symptoms","volume":"178","author":"Sinha","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114840_bib0160","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2147\/TCRM.S117321","article-title":"Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review","volume":"13","author":"Solmi","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0161","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1997.tb48274.x","article-title":"Noradrenergic alterations in posttraumatic stress disorder","volume":"821","author":"Southwick","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0162","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.smrv.2007.08.008","article-title":"Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature?","volume":"12","author":"Spoormaker","year":"2008","journal-title":"Sleep Med. Rev."},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0163","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr."},{"issue":"1 Suppl 1","key":"10.1016\/j.psychres.2022.114840_bib0164","first-page":"25","article-title":"Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines","volume":"14","author":"Stein","year":"2009","journal-title":"CNS Spectr."},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0165","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.euroneuro.2016.07.002","article-title":"Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects","volume":"26","author":"Struyk","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0166","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopsych.2007.07.001","article-title":"Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study","volume":"63","author":"Taylor","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0168","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jts.20351","article-title":"Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosin","volume":"21","author":"Thompson","year":"2008","journal-title":"J. Trauma. Stress"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0169","first-page":"135","article-title":"Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo","volume":"37","author":"Tucker","year":"2003","journal-title":"Psychopharmacol. Bull."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.v68n0204","article-title":"Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study","volume":"68","author":"Tucker","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0171","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.addbeh.2013.01.027","article-title":"Trauma histories, substance use coping, PTSD, and problem substance use among sexual assault victims","volume":"38","author":"Ullman","year":"2013","journal-title":"Addict. Behav."},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0172","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.2020.1817639","article-title":"Efficacy of psychoactive drugs for the treatment of posttraumatic stress disorder: a systematic review of MDMA, ketamine, LSD and psilocybin","volume":"53","author":"Varker","year":"2020","journal-title":"J. Psychoact. Drugs"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0173","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/acer.13969","article-title":"Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder","volume":"43","author":"Verplaetse","year":"2019","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"12","key":"10.1016\/j.psychres.2022.114840_bib0174","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2016.15070967","article-title":"Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial","volume":"173","author":"Villarreal","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0175","first-page":"8","article-title":"Characterizing the effects of quetiapine in military post-traumatic stress disorder","volume":"48","author":"Villarreal","year":"2018","journal-title":"Psychopharmacol. Bull."},{"issue":"7","key":"10.1016\/j.psychres.2022.114840_bib196","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamapsychiatry.2020.0036","article-title":"Effects of antipsychotic medication on brain structure in patients With major depressive disorder and psychotic features: neuroimaging findings in the context of a randomized placebo-controlled clinical trial","volume":"77","author":"Voineskos","year":"2020","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0176","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X","article-title":"Subjective hypnotic efficacy of trazodone and zolpidem in DSMIII\u2013R primary insomnia","volume":"13","author":"Walsh","year":"1998","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0177","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bdi.12860","article-title":"The psychopharmacology algorithm project at the Harvard south shore program: an update on bipolar depression","volume":"22","author":"Wang","year":"2020","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0178","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2001-15871","article-title":"Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares","volume":"34","author":"Warner","year":"2001","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2022.114840_bib0179","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brs.2011.02.002","article-title":"A sham controlled study of repetitive transcranial magnetic stimulation for posttraumatic stress disorder","volume":"5","author":"Watts","year":"2012","journal-title":"Brain Stimul."},{"issue":"3","key":"10.1016\/j.psychres.2022.114840_bib0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pas0000486","article-title":"The PTSD checklist for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans","volume":"30","author":"Weathers","year":"2018","journal-title":"Psychol Assess"},{"issue":"11","key":"10.1016\/j.psychres.2022.114840_bib0181","first-page":"8","article-title":"Evaluation of clonidine and prazosin for the treatment of nighttime posttraumatic stress disorder symptoms","volume":"32","author":"Wendell","year":"2015","journal-title":"Federal Pract."},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0182","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ADM.0000000000000413","article-title":"A randomized, placebo-controlled, clinical trial of prazosin for the treatment of alcohol use disorder","volume":"12","author":"Wilcox","year":"2018","journal-title":"J. Addict. Med."},{"issue":"9","key":"10.1016\/j.psychres.2022.114840_bib0183","doi-asserted-by":"crossref","first-page":"11266","DOI":"10.4088\/JCP.14m09475","article-title":"Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with posttraumatic stress disorder","volume":"76","author":"Wilkinson","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2022.114840_bib0184","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1592\/phco.30.10.1011","article-title":"Statistically significant increase in weight caused by low-dose quetiapine","volume":"30","author":"Williams","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.1L320","article-title":"Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions","volume":"43","author":"Wine","year":"2009","journal-title":"Ann. Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.psychres.2022.114840_bib0186","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1037\/pas0000260","article-title":"Psychometric analysis of the PTSD Checklist-5 (PCL-5) among treatment-seeking military service members","volume":"28","author":"Wortmann","year":"2016","journal-title":"Psychol. Assess."},{"issue":"6","key":"10.1016\/j.psychres.2022.114840_bib0187","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopsych.2005.04.022","article-title":"Antidepressants and periodic leg movements of sleep","volume":"58","author":"Yang","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2022.114840_bib0188","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1755-5949.2010.00188.x","article-title":"A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD","volume":"17","author":"Yeh","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.psychres.2022.114840_bib0189","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.602447","article-title":"Key Clinical Interest outcomes of pharmaceutical administration for veterans with post-traumatic stress disorder based on pooled evidences of 36 randomised controlled trials with 2,331 adults","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2022.114840_bib0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/JCP.0b013e31819a4bae","article-title":"Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial","volume":"29","author":"Ziegenhorn","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2022.114840_bib0191","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1176\/appi.ajp.2018.17090995","article-title":"Doubly randomized preference trial of prolonged exposure versus sertraline for treatment of PTSD","volume":"176","author":"Zoellner","year":"2019","journal-title":"Am. J. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122004334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122004334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:58:46Z","timestamp":1759039126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122004334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":194,"alternative-id":["S0165178122004334"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114840","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An evidence-based approach to psychopharmacology for posttraumatic stress disorder (PTSD) - 2022 update","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114840"}}